Article in THE LANCET
In THE LANCET of June 25th issue 9784 Prof. Dennis Turk PhD, Hillary D Wilson PhD & Prof. Alex Cahana MD Published an article on treatment of chronic non-cancer pain.
In an editorial article The Lancet refer to the Human Rights Watch Report Global Sate of Pain Treatment and coment on it as follows; "No human being is fortunate enough to live a life free of any pain, but, thankfully for most, such experiences are not severe. For many people, however, pain is enduring, debilitating, and devastating and arises after an operation, injury, or onset of disease. WHO estimates that 20% of individuals worldwide live with some degree of chronic pain. In the USA alone, pain is cited as the most common reason for accessing the health-care system. And, as Human Rights Watch note in a new report, millions of people with life-threatening illnesses suffer unnecessarily from severe pain because they lack access to palliative care." ""
The summary of the article of Turk e.a. you find here below
Chronic pain is a pervasive problem that affects the patient, their significant others, and society in many ways. The past decade has seen advances in our understanding of the mechanisms underlying pain and in the availability of technically advanced diagnostic procedures; however, the most notable therapeutic changes have not been the development of novel evidenced-based methods, but rather changing trends in applications and practices within the available clinical armamentarium. We provide a general overview of empirical evidence for the most commonly used interventions in the management of chronic non-cancer pain, including pharmacological, interventional, physical, psychological, rehabilitative, and alternative modalities. Overall, currently available treatments provide modest improvements in pain and minimum improvements in physical and emotional functioning. The quality of evidence is mediocre and has not improved substantially during the past decade. There is a crucial need for assessment of combination treatments, identification of indicators of treatment response, and assessment of the benefit of matching of treatments to patient characteristics.